Skip to content

Clinical trials

Phase 3 Fallopian Tube Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Phase: Phase 3 Country / region: France Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20053
20061
20091
20101
20112
20141
20161
20171
20181
20191
20211
20222
20231
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting4
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
AGO Study Group2
AbbVie2
Amgen2
European Organisation for Research and Treatment of Cancer - EORTC2
Medical Research Council2
Novartis Pharmaceuticals2
ARCAGY/ GINECO GROUP1
Corcept Therapeutics1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms23
Ovarian Neoplasms22
Carcinoma, Ovarian Epithelial10
Peritoneal Neoplasms6
Neoplasms2
Brenner Tumor1
Genital Diseases, Female1
Neoplasm Metastasis1
Ovarian Diseases1
Recurrence1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.